Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis

Lucy J Hathaway1, Denis Grandgirard2, Luca G Valente2

  • 1Institute for Infectious Diseases, Faculty of Medicine, University of Bern, Bern 3001, Switzerland lucy.hathaway@ifik.unibe.ch.

Open Biology
|March 25, 2016
PubMed

Insights

The capsule type of Streptococcus pneumoniae directly impacts meningitis severity. Specific serotypes, like 6B, cause more mortality and brain damage than others, highlighting the importance of capsule type in disease.

Area of Science:

  • Microbiology
  • Immunology
  • Neurology

Background:

  • Streptococcus pneumoniae has over 90 serotypes based on polysaccharide capsule composition.
  • While some serotypes cause carriage and others invasive disease, the severity of invasive disease by carriage serotypes is unknown.
  • The direct contribution of capsule type versus other virulence factors to disease severity remains unclear.

Purpose of the Study:

  • To determine the direct effect of pneumococcal capsule type on meningitis severity.
  • To isolate the impact of capsule type from other genetic factors using capsule-switch mutants.
  • To investigate the role of capsule in the infant rat model of pneumococcal meningitis.

Main Methods:

  • Utilized a clinical isolate of Streptococcus pneumoniae and its capsule-switch mutants.
  • Inoculated infant rats to establish a meningitis model.
  • Assessed mortality, capsule thickness in cerebrospinal fluid (CSF), inflammatory cytokine response in CSF, and cortical brain damage.

Main Results:

  • A polysaccharide capsule is essential for Streptococcus pneumoniae to cause meningitis.
  • Serotype 6B demonstrated significantly higher mortality rates compared to serotype 7F.
  • Increased capsule thickness in CSF, heightened inflammatory cytokine response, and greater cortical brain damage were observed with serotype 6B.

Conclusions:

  • Pneumococcal capsule type directly influences the severity of meningitis.
  • Capsule characteristics, such as thickness, correlate with disease outcomes.
  • Findings are critical for understanding serotype replacement in the context of current vaccination strategies targeting specific capsule types.